Repella Robert
Insider CIK 1532513 · VNDA SVP & Chief Commercial Officer · BHVN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-05-21 | 2019-05-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2018-09-07 | 2018-09-11 | 36,000 | — | $0 | 36,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-11-21 | 2013-11-21 | 34,570 | — | $0 | 21,680 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-11-21 | 2013-11-21 | 23,040 | — | $0 | 166,445 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-11-21 | 2013-11-21 | 23,040 | $5.90 | $135.9K | 44,530 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-11-21 | 2013-11-21 | 34,570 | $3.12 | $107.9K | 79,100 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2013-11-21 | 2013-11-21 | 64,100 | $12.12 | $776.9K | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-11-20 | 2013-11-21 | 40,515 | — | $0 | 189,485 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2013-11-20 | 2013-11-21 | 40,515 | $11.89 | $481.7K | 21,490 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-11-20 | 2013-11-21 | 40,515 | $5.90 | $239.0K | 62,005 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2013-11-19 | 2013-11-21 | 2,885 | $12.07 | $34.8K | 21,490 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-07-29 | 2013-07-31 | 9,375 | — | $0 | 9,375 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-07-29 | 2013-07-31 | 9,375 | — | $0 | 24,375 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2013-02-14 | 2013-02-19 | 15,000 | — | $0 | 45,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2013-02-14 | 2013-02-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-12-07 | 2012-12-11 | 18,750 | — | $0 | 18,750 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-12-07 | 2012-12-11 | 56,250 | — | $0 | 56,250 | SEC↗ |